digital currency fed Top See results about

1 trillion yuan of ultra-long-term special government bonds have been arranged! The combination of boxing has been effective. At present, the "double"+"two new" annual 1 trillion yuan ultra-long-term special national debt has all been arranged. In November, the purchasing managers' index of manufacturing industry reached 50.3%, rising for three consecutive months. The "two-fold" and "two innovations" package of incremental policies is effectively promoting the sustained and steady progress of the economy. (CCTV News)Low-altitude economic concept stocks strengthened locally, with Guangyang shares and Rice Information up more than 6%, and Tianao Electronics, Wan Feng Aowei and Jindun shares up more than 5%.Big financial stocks rose in intraday trading, with great wisdom hitting the daily limit. Tianmao Group, Guosheng Financial Holdings and Tianli Technology had previous daily limit, while huijin technology, Compass, Winson, Dongxing Securities and Oriental Fortune rose more than 5%.

Big financial stocks rose in intraday trading, with great wisdom hitting the daily limit. Tianmao Group, Guosheng Financial Holdings and Tianli Technology had previous daily limit, while huijin technology, Compass, Winson, Dongxing Securities and Oriental Fortune rose more than 5%.General Administration of Customs: Import and export of general trade and processing trade increased. According to customs statistics, in the first 11 months, China's general trade import and export was 25.5 trillion yuan, an increase of 3.7%, accounting for 64.1% of China's total foreign trade. Among them, the export was 15.04 trillion yuan, up by 7.9%; Imports reached 10.46 trillion yuan, down 1.8%. In the same period, the import and export of processing trade was 7.22 trillion yuan, up by 3.6%, accounting for 18.1%. Among them, exports were 4.58 trillion yuan, an increase of 1.8%; Imports reached 2.64 trillion yuan, up 6.9%. In addition, China's import and export by bonded logistics was 5.64 trillion yuan, an increase of 13%. Among them, exports were 2.2 trillion yuan, an increase of 10.9%; Imports reached 3.44 trillion yuan, up by 14.4%.Significant progress in domestic growth hormone! Jichuan Pharmaceutical Co., Ltd. and Tianjing Biological Co., Ltd. announced that the listing application of Etan long-acting growth hormone was accepted, with a height of 10.76 cm a year, which made significant progress in domestic growth hormone. Today, Tianjing Bio and Jichuan Pharmaceutical jointly announced that the application for marketing biological products of Etan long-acting recombinant human growth hormone injection (hereinafter referred to as "Etan long-acting growth hormone") for treating children's growth hormone deficiency (PGHD) has been accepted by NMPA. As the first and only long-acting growth hormone with fusion protein in the domestic application stage and listed products, this innovative therapy is expected to provide safe, effective and convenient treatment options for children with growth hormone deficiency. Etan long-acting growth hormone adopts innovative hyFc® fusion protein technology, which greatly improves the stability and half-life of the drug by combining human growth hormone with specially designed human immunoglobulin. This patented technology not only ensures the biological activity of growth hormone, but also realizes the long-acting function of growth hormone in the body, thus making Ethan the first fusion protein long-acting growth hormone to be administered once a week.

Significant progress in domestic growth hormone! Jichuan Pharmaceutical Co., Ltd. and Tianjing Biological Co., Ltd. announced that the listing application of Etan long-acting growth hormone was accepted, with a height of 10.76 cm a year, which made significant progress in domestic growth hormone. Today, Tianjing Bio and Jichuan Pharmaceutical jointly announced that the application for marketing biological products of Etan long-acting recombinant human growth hormone injection (hereinafter referred to as "Etan long-acting growth hormone") for treating children's growth hormone deficiency (PGHD) has been accepted by NMPA. As the first and only long-acting growth hormone with fusion protein in the domestic application stage and listed products, this innovative therapy is expected to provide safe, effective and convenient treatment options for children with growth hormone deficiency. Etan long-acting growth hormone adopts innovative hyFc® fusion protein technology, which greatly improves the stability and half-life of the drug by combining human growth hormone with specially designed human immunoglobulin. This patented technology not only ensures the biological activity of growth hormone, but also realizes the long-acting function of growth hormone in the body, thus making Ethan the first fusion protein long-acting growth hormone to be administered once a week.Market News: South Korea's National Power Party discusses Yin Xiyue's stepping down in February or March.Philippine imports increased by 11.2% year-on-year in October, while exports decreased by 5.5% year-on-year.